Fingerprint
Dive into the research topics of 'Carfilzomib: A second-generation proteasome inhibitor for the treatment of multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Carfilzomib: A second-generation proteasome inhibitor for the treatment of multiple myeloma
Ali McBride, Jeff O. Klaus, Keith Stockerl-Goldstein
Research output: Contribution to journal › Review article › peer-review
53
Scopus
citations